BothCases
Example report. Sign up to run the same analysis on any ticker.
NBIS logoNBISEquity research

Report date: 2026-11-09

$82.64-14.28 (-14.73%)Live · delayed quote, informational only

Analysis focus

Provide a balanced, comprehensive analysis: fundamentals and valuation, the Wall Street view, technical posture, and the key forward risks and catalysts.

Summary

Nebius (NBIS) closed at $129.49 on November 6, 2026, a market capitalization of roughly $35.2-35.5 billion and an enterprise value of about $37.65 billion on 271.9 million shares [3]. The shares are down about 52% from the October 6 close of $249.87 and roughly 55% below the June 18 record close of $286.69, yet still up 54.70% year-to-date and 18.32% over twelve months [7][17][24]. The fundamental picture is one of extreme growth funded by extreme spending. Q2 2026 revenue was $582.3 million (+454% year over year) with adjusted EBITDA of $236.2 million, but the GAAP net loss from continuing operations was $190.4 million, or $(0.68) per diluted share, and the adjusted net loss was $33.2 million [13][20]. First-half net income of $430.8 million should be normalized for a one-time $780.6 million equity-revaluation gain booked in Q1, which also renders the trailing P/E of roughly 490x to 788x meaningless [12][20]. Cash burn is the central debate: Q2 operating cash flow of $2.25 billion, itself boosted by customer prepayments and nearly $6 billion of deferred revenue, was swamped by $5.66 billion of capex, leaving quarterly free cash flow near $(3.4) billion and trailing FCF near $(5.88) billion; the company has since layered on $5.75 billion of convertibles and a $3.5 billion Citi facility, and Rosenblatt's model does not reach FCF breakeven until 2034 [1][15]. On valuation, the stock trades at about 26x trailing sales and 27.8x EV/sales but only about 4.9x forward sales and roughly 13x next-twelve-month EV/EBITDA, a compression that depends on delivering roughly $2 billion of second-half revenue, more than double the $981 million first half, to meet the $3.0-3.4 billion 2026 guidance [8][12][21]. Versus CoreWeave, Nebius carries far less leverage (about $2.15 billion net debt at June 30 versus roughly $30 billion) and prepayments on about 70% of Q2 deals versus 15-25%, but trades at a higher multiple of 7.8x 2028 EV/EBITDA versus 2.9x per Rosenblatt, and 26.2x trailing sales versus 3.4x [11][19]. A true five-year multiple history is unavailable because NBIS has traded under this name for only about two years [12]. The Wall Street view is constructive on paper but moving the wrong way. Twenty-two analysts tracked by S&P Global rate the stock a consensus Buy (13 Strong Buy, 2 Buy, 6 Hold, 1 Strong Sell) with a $278.05 average target and a $287.50 median, implying more than double the current price, though consensus varies by aggregator from about $266 to $297 [2][5][14]. Recent actions skew toward trimming: Citi cut to $265 from $324 on November 4 while keeping Buy, Piper Sandler cut to $185 from $237 with a Neutral, citing AI demand, return on invested capital, financing and component-cost concerns, and Morgan Stanley sits at Hold with a $144 target that implies only about 11% upside [6][14][16]. Rothschild & Co Redburn's $84 Sell target, about 35% below the close, anchors the bear case, while Northland's $410, Exane BNP's $399 and Goldman's $328 anchor the bull case [6][16]. Hold-rated analysts have generally cited price rather than demand, as with Freedom Capital's valuation-driven April downgrade [22]. The technical posture is firmly bearish: the stock sits about 36% below its 50-day moving average of $201.70 and 27% below its 200-day average of $178.38, with RSI near 34 after dipping below 30 the prior week, MACD negative at about -20.6, and Investtech flagging a broken $148 support, an exit from the medium-term rising channel and a downside objective near $78.59 [4][9][18][23]. Near-term support clusters at about $122.65 and $115.57 with resistance at $134-137 and $144-148 [23]. The 7.58% bounce on November 6 came alongside a sector rally after a rival's AI-cloud beat, in a stock with 20.83% of float sold short and a beta of 1.54, which magnifies both squeezes and drawdowns [10]. The key catalyst is the Q3 2026 report on November 12 before the open, where consensus expects roughly $905-907 million of revenue and a loss of about $0.71-0.72 per share, along with any update to the $20-25 billion 2026 capex guidance, the $7-9 billion year-end ARR target and the 800 MW to 1 GW connected-power target [2][8][15][21][22]. Forward risks cited by both camps include customer concentration (three customers were 59% of Q2 revenue, with Microsoft and Meta contracts each exceeding $10 billion), the November 4 Bloomberg report that Microsoft was tightening oversight of some Nebius data-center projects and the subsequent CNBC report that Microsoft plans to use fewer neoclouds, dilution from the at-the-market program and convertibles, GPU pricing durability with market H100 rates of about $2.80-3.60 per hour versus Nebius's $4.50 list price, and consensus net debt rising to about $14 billion by end-2026 and $34 billion by end-2027 [15][22][24]. Offsetting factors include backlog above $40 billion and roughly $37.5 billion of remaining performance obligations, expected 2026 prepayments above $9 billion, a balance sheet that is far less levered than CoreWeave's, and a forward multiple that has already compressed from roughly 24x expected 2026 sales at the June peak to under 5x today [8][15][19][21]. The reader is left weighing a business whose demand indicators remain strong against a funding model that depends on continued capital-market access and flawless capacity delivery.

Findings (24)

Nebius generated $2,246.1 million of operating cash flow in Q2 2026 but spent $5,657.4 million on capex, implying roughly $(3.4) billion of quarterly free cash flow and about $(5.88) billion trailing-twelve-month FCF; at June 30, 2026 it held $8,042.1 million of cash against $8,545.7 million of debt, before adding $5.75 billion of convertible notes in August and a $3.5 billion Citi facility in October.

High confidence

The 6-K reports Q2 operating cash flow of $2,246.1 million, capex of $5,657.4 million, cash of $8,042.1 million and total debt of $8,545.7 million; operating cash flow is boosted by customer prepayments (deferred revenue of $979.4 million current plus $4,995.8 million non-current). StockAnalysis shows TTM FCF of -$5.88B and total debt of $10.20B after the convertible; StockTitan lists the $5.75B convertible closing (Aug 24, 2026) and the $3.5B Citi facility; Rosenblatt cites Q2 FCF of -$3.41 billion and 2026 capex guidance of $20-25 billion.

Wall Street remains mostly constructive but is trimming targets ahead of the Nov 12 Q3 report: 22 analysts average a $278.05 target (range $84 Rothschild Redburn Sell to $410 Northland), Citi cut to $265 from $324 on Nov 4 while keeping Buy, and Piper Sandler cut to $185 from $237 with a Neutral on Oct 21; consensus Q3 revenue is about $907M with a loss of $0.72 per share.

High confidence

Yahoo Finance shows the $278.05 average, $84–$410 range and Citi's Nov 4 cut; TipRanks lists 9 Buy / 3 Hold / 1 Sell with Citi, Piper Sandler and Rosenblatt actions; MarketBeat gives the Nov 12 date and $907M / -$0.72 consensus; stockanalysis.com confirms the Nov 12 pre-market release.

NBIS closed at $129.49 on November 6, 2026 (about $130.78 in the November 8 quote), giving a market capitalization of roughly $35.2-35.5 billion and an enterprise value of about $37.65 billion on 271.9 million shares outstanding.

High confidence

StockAnalysis (updated Nov 9, 2026) lists a $129.49 Nov 6 close, $35.49B market cap and $37.65B EV; Robinhood shows $130.78 and $35.19B as of Nov 8; StockTitan shows ~$35.6B on 271.9M shares, consistent with the 271,855,218 shares reported in the Q2 2026 6-K.

Technically the stock is in a sharp downtrend: at $129.49 it sits about 36% below its 50-day moving average of $201.70 and 27% below its 200-day average of $178.38, with RSI near 34, a 52-week range of $73.52 to $299.86, short interest of 17.4% of shares outstanding, and a 12.18% single-day drop to $165.47 on October 16, 2026 tied to CoreWeave's debt scare.

High confidence

StockAnalysis lists the 50-day MA at 201.70, 200-day MA at 178.38, RSI 34.03, beta 1.54 and short interest of 17.38% of shares outstanding (20.83% of float); Robinhood shows the $299.86 high and $73.52 low; TIKR documents the $165.47 close on October 16, 2026 after a 12.18% decline. Percentage distances from the moving averages are derived from these figures.

As of the Nov 4, 2026 update, 22 analysts tracked by S&P Global rate NBIS a consensus Buy (13 Strong Buy, 2 Buy, 6 Hold, 0 Sell, 1 Strong Sell) with an average 12-month target of $278.05, a median of $287.50, and a range of $84 to $410, versus a Nov 6 close of $129.49.

High confidence

StockAnalysis lists the 22-analyst breakdown, $278.05 average (+114.7% implied), $287.50 median, $84 low and $410 high. TipRanks (13 analysts, 9 Buy/3 Hold/1 Sell, $296.73 average) and WallStreetZen (15 analysts, $266.07 average) show the consensus varies by aggregator but all sit well above twice the current price.

Outside the bulge brackets, Piper Sandler's James Fish cut the target to $185 from $237 (Hold) on Oct 21, 2026; Exane BNP Paribas' Stefan Slowinski upgraded to Buy and raised to $399 from $260 on Sep 24; Rothschild & Co Redburn's Alexander Haissl initiated at Sell with an $84 target the same day; and Rosenblatt's John McPeake initiated at Buy with $304 on Oct 7.

High confidence

TipRanks shows all four actions with analyst names and target changes; WallStreetZen confirms the Rothschild Sell at $84 (-35% implied) plus Truist's $355 and Northland's $410 Buy targets. The $84 low target and $410 high target define the consensus range and sit roughly 35% below and 217% above the Nov 6 close.

Technically, NBIS closed at $129.49 on Nov 6, 2026 (+7.58% that day), about 55% below its $286.69 record close of June 18, below both its 50-day ($201.70) and 200-day ($178.38) moving averages, with a 14-day RSI of 34 and a 52-week range of $73.52 to $299.86.

High confidence

StockAnalysis statistics page (updated Nov 9) lists the moving averages, RSI 34.03, beta 1.54 and a 52-week change of +10.7%; the overview page gives the $73.52/$299.86 range and $35.49B market cap. The Motley Fool article records the $286.69 record close on June 18 and noted the stock was already down ~40% by Oct 19 at ~$165, with about 30 points of that drop occurring in October.

The next catalyst is the Q3 2026 report on Nov 12, 2026, where consensus expects revenue of roughly $905M (17 analysts) and a loss of about $0.71 per share; meeting full-year guidance requires second-half revenue of about $2B, more than double the $981M first half.

High confidence

Equibles cites $904.8M consensus Q3 revenue and reaffirmed guidance of $3.0B to $3.4B revenue, ~40% adjusted EBITDA margin and $20B to $25B capex; StockAnalysis lists the Nov 12 earnings date. The Fool article derives the ~$2B second-half requirement from first-half revenue of $981M and flags ~$37.5B of remaining performance obligations, of which only ~36% is expected to convert within two years.

RSI(14) stood at 34.03 as of the Nov 6 close (34.38 on Nov 7), just above the 30 oversold threshold after dipping below 30 during the prior week, while MACD remained negative at about -20.6.

High confidence

stockanalysis.com shows RSI 34.03 and TipRanks shows MACD -20.63 for Nov 6; Blockchain.News reports RSI 34.38 and MACD -17.38 on Nov 7; Investtech's Nov 6 analysis says short-term momentum was 'strongly negative, with RSI below 30' before the Nov 6 bounce, i.e. near-oversold rather than deeply oversold now.

NBIS rebounded 7.58% on Nov 6 (from $120.37 to $129.49) alongside other neoclouds after a rival's AI-cloud beat, in a stock with 20.83% of float sold short and a 5-year beta of 1.54, which magnifies both squeezes and drawdowns.

High confidence

stockanalysis.com statistics list short interest at 20.83% of float and beta 1.54; Yahoo's news feed carries the TIKR headline 'Nebius Soars 7% as a Rival's AI Cloud Beat Lifts Neoclouds'; TipRanks' Nov 6 coverage confirms the +7.58% close and the sector rally after the prior day's selloff.

Fundamentally, Q2 2026 revenue was $582.3M (+454% YoY) with adjusted EBITDA of $236.2M but a $190.4M net loss from continuing operations and $5.66B of quarterly capex; first-half net income of $430.8M was flattered by $780.6M of one-time equity-revaluation gains, and the stock trades at 26.2x trailing sales (4.9x forward) versus CoreWeave at 3.4x trailing sales.

High confidence

The company's Aug 12, 2026 6-K press release reports Q2 revenue $582.3M vs $105.1M, adjusted EBITDA $236.2M, net loss from continuing ops $(190.4)M, six-month equity revaluation gains of $780.6M and Q2 capex of $5,657.4M; stockanalysis.com lists NBIS P/S 26.19, forward P/S 4.94 and EV/Sales 27.78 versus CoreWeave P/S 3.37 and EV/Sales 9.44. The forward multiple compresses sharply because the $8.0B cash pile and deferred-revenue-backed growth are expected to lift 2026–27 sales.

Nebius trades at roughly 26x trailing sales (about 4.9x forward sales), 3.4x book, ~146x trailing EV/EBITDA and ~13x next-twelve-month EV/EBITDA, pays no dividend, and its trailing P/E (reported anywhere from ~490x to ~788x) is not meaningful because trailing EPS of $0.16 is driven by non-operating equity revaluation gains.

Medium confidence

StockAnalysis shows P/S 26.19 (forward 4.94), P/B 3.43, EV/EBITDA 145.92, trailing P/E 788.31, EPS TTM $0.16 and no dividend; Robinhood shows P/E 489.75; TIKR cites ~13x NTM EV/EBITDA. The Q2 2026 6-K shows a $780.6 million revaluation gain on equity securities in the first six months of 2026, which is what makes trailing EPS positive despite an operating loss. Nebius has traded as NBIS for only about two years, so a true 5-year multiple history is unavailable; the gap between 26x trailing and ~5x forward sales reflects expected revenue growth rather than a historical range.

In its most recent reported quarter (Q2 2026, ended June 30, 2026), Nebius posted revenue of $582.3 million (+454% YoY), adjusted EBITDA of $236.2 million, a GAAP net loss from continuing operations of $(190.4) million and diluted EPS of $(0.68), with an adjusted net loss of $(33.2) million after excluding items such as $49.9 million of acquisition-related costs.

High confidence

The Q2 2026 results exhibit filed with the SEC on August 12, 2026 states revenue of $582.3 million versus $105.1 million a year earlier, adjusted EBITDA of $236.2 million, net loss from continuing operations of $(190.4) million and diluted EPS of $(0.68). One-time/non-operating items to normalize: no equity revaluation gain in Q2 2026 (versus $597.4 million in Q2 2025), a $21.1 million FX gain, $81.5 million other income, $49.9 million acquisition costs, and $119.1 million interest expense; six-month net income of $430.8 million is inflated by the $780.6 million Q1 2026 revaluation gain.

Wall Street is split: Rosenblatt initiated at Buy with a $304 target on October 7, 2026, Piper Sandler cut its target to $185 from $237 and kept a Hold on October 23, 2026, and the consensus mean target is roughly $284-297 with a range of $84 to $410 across about 23-26 ratings that are roughly two-thirds Buy.

Medium confidence

Yahoo Finance reports Rosenblatt analyst John McPeake's Buy/$304 initiation; TipRanks reports Piper Sandler's $237-to-$185 cut with a reiterated Hold citing AI demand, ROIC and financing concerns and rising component costs; TIKR shows a ~$284 mean target, $84-$410 range and 13 Buy/2 Outperform/6 Hold/1 Underperform/1 Sell; Robinhood shows 26 ratings at 65.4% Buy, 30.8% Hold, 3.8% Sell. Consensus figures differ by aggregator and were set when the stock traded well above current levels.

The next catalyst is Q3 2026 results on November 12, 2026 before the open, where consensus expects roughly $905 million of revenue, against a backdrop of guided 2026 capex of $20-25 billion, backlog above $40 billion, consensus net debt rising to about $14 billion by end-2026 and ~$34 billion by end-2027, and a Rosenblatt model that does not turn free-cash-flow positive until 2034.

Medium confidence

StockTitan and StockAnalysis both show the Q3 2026 report scheduled for November 12, 2026 before market open; TIKR cites ~$905 million consensus Q3 revenue, net debt projections of ~$14B (end-2026) and ~$34B (end-2027), interest expense rising to ~$1.1B in 2027 and 2027 consensus revenue of ~$12.3B with ~$6.6B EBITDA; Rosenblatt cites $20-25B 2026 capex, >$40B backlog, >$9B expected 2026 prepayments, 800 MW-1 GW connected power by year-end 2026 and FCF breakeven not until 2034. Projections are analyst estimates, not company-reported figures.

In the last 90 days, major-bank actions include Citi's Tyler Radke cutting the target to $265 from $324 (Buy) on Nov 4, 2026; Bank of America's Tal Liani reiterating Buy at $310 on Oct 22; Goldman Sachs' Alexander Duval raising to $328 from $286 (Buy) on Aug 25; and Morgan Stanley's Ryan Lountzis at Hold with a $144 target on Aug 13.

High confidence

Both TipRanks and StockAnalysis list the Citi, BofA, Piper and Rosenblatt actions with the same dates and targets; TipRanks additionally shows the Goldman ($286 to $328) and Morgan Stanley ($144 Hold) entries. Against the $129.49 close, Citi implies +105%, BofA +139%, Goldman +153%, and Morgan Stanley only +11%. No JPMorgan, Wells Fargo or Barclays rating was found in any aggregator.

NBIS closed at $129.49 on November 6, 2026, down 33.63% over six months but up 18.32% over twelve months and 54.70% year-to-date, within a 52-week range of $73.52 to $299.86.

High confidence

Yahoo Finance's quote page lists the Nov 6 close of $129.49 with 6-month -33.63%, 1-year +18.32% and YTD +54.70% performance; stockanalysis.com confirms the same close and the $73.52–$299.86 52-week range.

At $129.49 the stock trades roughly 36% below its 50-day moving average of $201.70 and roughly 27% below its 200-day moving average of $178.38, with the 50-day sitting above the 200-day (no death cross yet).

High confidence

Both stockanalysis.com statistics (updated Nov 9) and TipRanks' Nov 6 technical report list the 50-day MA at $201.70 and 200-day MA at $178.38; TipRanks rates price-below-all-MAs as a bearish trend. Percentages are computed from those figures.

Versus peer CoreWeave, Nebius carries far less leverage (about $2.15 billion net debt at June 30, 2026 versus CoreWeave's roughly $30 billion net debt on $35.6 billion of indebtedness) and secured prepayments on about 70% of Q2 2026 deals versus 15-25% for CoreWeave, but trades at a higher multiple of 7.8x 2028 EV/EBITDA versus 2.9x for CoreWeave per Rosenblatt.

Medium confidence

TIKR reports Nebius LTM net debt of $2,153.2 million versus CoreWeave's $35.6 billion total indebtedness and $5.524 billion cash at June 30 (~$30 billion net); Rosenblatt's October 7, 2026 initiation cites 7.8x 2028 EV/EBITDA for Nebius versus 2.9x for CoreWeave and Q2 FCF of -$3.41B (NBIS) versus -$5.74B (CRWV); Piper Sandler's James Fish cites the 70% versus 15-25% prepayment comparison. Multiples are analyst estimates, not reported figures.

Per the company's Aug 12, 2026 6-K, Q2 2026 revenue was $582.3M (+454% YoY), adjusted EBITDA was $236.2M, and net loss from continuing operations was $190.4M; first-half net income of $430.8M was flattered by a one-time $780.6M gain on revaluation of equity securities that should be excluded when assessing underlying profitability.

High confidence

The SEC-filed press release exhibit reports the Q2 and six-month revenue, adjusted EBITDA, net loss, the $780.6M six-month equity revaluation gain (zero in Q2 itself), $49.9M of acquisition/transaction costs, $8.04B of cash ($9.10B including restricted cash) and $5.66B of Q2 capital expenditures. Adjusted net loss was $33.2M.

Nebius trades at roughly 26x trailing sales and 27.8x EV/sales ($37.65B enterprise value on $1.36B TTM revenue) but only about 4.9x forward sales, down from roughly 24x expected 2026 sales at the June peak and about 15x in mid-October, as the company guides to $3.0B to $3.4B of 2026 revenue and $7B to $9B of year-end ARR.

Medium confidence

StockAnalysis provides the trailing P/S 26.19, forward P/S 4.94, EV/Sales 27.78 and P/B 3.43. The Fool piece gives the ~24x (June) and ~15x (October) multiples of 2026 guidance, and Equibles puts EV at 15.2x FY2026 consensus revenue of $3.34B and 4.1x FY2027 consensus of $12.29B; the forward multiple is only meaningful if the steep second-half ramp is delivered. Versus peer CoreWeave, Equibles notes Nebius carries ~$14.2B gross debt (mostly low-coupon convertibles) against ~$14.5B pro forma cash, while CoreWeave has ~$50B of debt with bonds yielding above 16%.

Key risks cited by both bulls and bears include customer concentration (three customers were 59% of Q2 2026 revenue), capacity-delivery timing against an 800 MW to 1 GW year-end connected-power target, dilution from the at-the-market program and convertibles, and GPU pricing durability with market H100 rates of about $2.80 to $3.60 per hour versus Nebius's $4.50 list price.

Medium confidence

Equibles and the Fool both report the 59% three-customer concentration and the Microsoft and Meta contracts each exceeding $10B; Equibles adds the power target, dilution sources, H100 pricing comparison, and Microsoft liquidated-damages terms. Earlier in 2026, Freedom Capital's downgrade to Hold (Apr 13, target $108 to $154) was explicitly valuation-driven, illustrating that Hold-rated analysts generally cite price rather than demand as the concern.

Near-term support is clustered at about $122.65 and $115.57 with resistance at roughly $134–137 and $144–148; Investtech flags that the former $148 support was broken and the stock has exited a medium-term rising trend channel.

Medium confidence

Blockchain.News lists pivot $129.89, supports $122.65/$115.57 and resistances $136.97/$144.21; Investtech cites resistance at $134, broken support at $148, a double-top signal and a downside objective of $78.59. The Nov 6 intraday range of $122.62–$136.87 on stockanalysis.com brackets these levels. Levels differ by provider, hence medium confidence.

The stock fell about 52% from its Oct 6 close of $249.87 to a Nov 5 close of $120.37, driven by sector-wide neocloud selling after Elon Musk's Oct 26 consolidation warning, Microsoft's below-expectations capex on Oct 28, a Nov 4 Bloomberg report that Microsoft was tightening oversight of some Nebius data-center projects (shares fell about 17% that session), and post-midterm AI-regulation worries.

Medium confidence

stockanalysis.com history shows the Oct 6 high close of $249.87 and the Nov 5 close of $120.37; its news feed lists CNBC/Reuters (Oct 26 Musk comments, Oct 28 Microsoft capex), TipRanks (Nebius and IREN down ~17% on the Bloomberg Microsoft-oversight report) and Invezz (Nov 4 regulation fears); TipRanks' news page adds the Nov 6 CNBC piece 'Microsoft plans to use fewer neoclouds.' The ~17% figure comes from a secondary summary, so confidence is medium.

Sources (27)

Caveats

All market data is as of the November 6, 2026 close (with some November 7-9 quotes) and will be stale after the November 12 Q3 report, which could materially change every forward-looking figure. The most recent company-reported financials are from Q2 2026 (June 30), so cash, debt and free-cash-flow figures predate the $5.75 billion August convertible and $3.5 billion October Citi facility; pro forma balance-sheet figures come from secondary sources (Equibles, TIKR, StockAnalysis) rather than SEC filings. Analyst consensus counts, averages and rating breakdowns differ across aggregators (StockAnalysis, TipRanks, WallStreetZen, Robinhood, TIKR), and most targets were set when the stock traded far above current levels. Forward multiples, net-debt projections, 2028 EV/EBITDA comparisons and the 2034 FCF-breakeven date are analyst estimates, not company guidance. The ~17% single-day drop attributed to the Microsoft-oversight report and the technical support/resistance levels come from secondary or blog-tier sources (TipRanks summaries, Blockchain.News, Investtech) and carry medium confidence. A five-year valuation history is unavailable because NBIS has traded under this name for only about two years. Not covered: detailed segment economics, the full text of the Microsoft and Meta contracts and their liquidated-damages terms, management commentary since August, power-delivery progress at specific sites, and any Q3 pre-announcements. No JPMorgan, Wells Fargo or Barclays rating was found.

This report is for informational purposes only and is not investment advice. No buy / sell / hold recommendation is made or implied.

More research reports

Recent reports from the same pipeline. See all examples

Want this on your watchlist?

Add your own focus, pick a delivery speed, and get a source-verified report like this one.